Fertility and Sterility
Volume 90, Issue 6 , Pages 2031-2055 , December 2008

Reproductive organ transplantation: advances and controversies

  • Mohamed A. Bedaiwy, M.D., Ph.D.

      Affiliations

    • Department of Obstetrics–Gynecology, The Cleveland Clinic Foundation, Cleveland, Ohio
    • ,
  • Ahmed Y. Shahin, M.D.

      Affiliations

    • Department of Obstetrics and Gynecology, Women's Health Centre, Assiut University, Assiut City, Egypt
    • ,
  • Tommaso Falcone, M.D.

      Affiliations

    • Department of Obstetrics–Gynecology, The Cleveland Clinic Foundation, Cleveland, Ohio
    • Corresponding Author InformationReprint requests: Tommaso Falcone, M.D., Department of Obstetrics and Gynecology, A81, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195 (FAX: 216-445-5526).

Received 5 August 2008 ,Revised 5 August 2008 ,Accepted 5 August 2008.

References 

  1. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Livebirth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;364:1405–1410
  2. Meirow D, Levron J, Eldar-Geva T, Ben Yehuda D, Dor J. Ovarian tissue storing for fertility preservation in clinical practice: successful pregnancy, technology, and risk assessment. Fertil Steril. 2005;84:S2
  3. Morishita S, Imai A, Kawabata I, Tamaya T. Acute myelogenous leukemia in pregnancy: fetal blood sampling and early effects of chemotherapy. Int J Gynaecol Obstet. 1994;44:273–277
  4. Silber SJ, Gosden RG. Ovarian transplantation in a series of monozygotic twins discordant for ovarian failure. N Engl J Med. 2007;356:1382–1384
  5. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7:1342–1346
  6. Gosden RG, Faddy MJ. Biological bases of premature ovarian failure. Reprod Fertil Dev. 1998;10:73–78
  7. Bhatavdekar JM, Shah NG, Patel DD, Karelia NH, Trivedi SN, Vora HH, et al. Endocrine function in premenopausal and postmenopausal advanced breast cancer patients treated with CMF or tamoxifen. Neoplasma. 1992;39:123–127
  8. Ludwig KS. The Mayer-Rokitansky-Kuster syndrome. An analysis of its morphology and embryology. Part II: embryology. Arch Gynecol Obstet. 1998;262:27–42
  9. Ozaki T, Flege S, Kevric M, Lindner N, Maas R, Delling G, et al. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol. 2003;21:334–341
  10. Del Priore G, Stega J, Sieunarine K, Ungar L, Smith JR. Human uterus retrieval from a multi-organ donor. Obstet Gynecol. 2007;109:101–104
  11. American Cancer Society. Cancer facts and figures. 2002; Available at: http://www.cancer.org (last accessed: May, 13, 2007).
  12. Blatt J. Pregnancy outcome in long-term survivors of childhood cancer. Med Pediatr Oncol. 1999;33:29–33
  13. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, et al. Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol. 1992;166:788–793
  14. Faddy MJ, Gosden RG. A mathematical model of follicle dynamics in the human ovary. Hum Reprod. 1995;10:770–775
  15. Warne GL, Fairley KF, Hobbs JB, Martin FI. Cyclophosphamide-induced ovarian failure. N Engl J Med. 1973;289:1159–1162
  16. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood. 1996;87:3045–3052
  17. Meirow D, Lewis H, Nugent D, Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Reprod. 1999;14:1903–1907
  18. Kenney LB, Laufer MR, Grant FD, Grier H, Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001;91:613–621
  19. Shalet SM. Effects of cancer chemotherapy on gonadal function of patients. Cancer Treat Rev. 1980;7:141–152
  20. Larsen EC, Muller J, Schmiegelow K, Rechnitzer C, Andersen AN. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 2003;88:5307–5314
  21. Schilsky RL, Sherins RJ, Hubbard SM, Wesley MN, Young RC, DeVita VT. Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med. 1981;71:552–556
  22. Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR, Motta PM. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod. 1993;8:7
  23. Tilly JL, Kolesnick RN. Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochim Biophys Acta. 2002;1585:135–138
  24. Morita Y, Perez GI, Paris F, Miranda SR, Ehleiter D, Haimovitz-Friedman A, et al. Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy. Nat Med. 2000;6:1109–1114
  25. Meirow D, Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7:535–543
  26. Lobo RA. Potential options for preservation of fertility in women. N Engl J Med. 2005;353:64–73
  27. Gaetini A, De Simone M, Urgesi A, Levis A, Resegotti A, Ragona R, et al. Lateral high abdominal ovariopexy: an original surgical technique for protection of the ovaries during curative radiotherapy for Hodgkin's disease. J Surg Oncol. 1988;39:22–28
  28. Williams RS, Littell RD, Mendenhall NP. Laparoscopic oophoropexy and ovarian function in the treatment of Hodgkin disease. Cancer. 1999;86:2138–2142
  29. Wallace WH, Thomson AB, Saran F, Kelsey TW. Predicting age of ovarian failure after radiation to a field that includes the ovaries. Int J Radiat Oncol Biol Phys. 2005;62:738–744
  30. Wallace WH, Thomson AB, Kelsey TW. The radiosensitivity of the human oocyte. Hum Reprod. 2003;18:117–121
  31. Husseinzadeh N, Nahhas WA, Velkley DE, Whitney CW, Mortel R. The preservation of ovarian function in young women undergoing pelvic radiation therapy. Gynecol Oncol. 1984;18:373–379
  32. Critchley HO, Wallace WH, Shalet SM, Mamtora H, Higginson J, Anderson DC. Abdominal irradiation in childhood; the potential for pregnancy. Br J Obstet Gynaecol. 1992;99:392–394
  33. Bath LE, Critchley HO, Chambers SE, Anderson RA, Kelnar CJ, Wallace WH. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement. Br J Obstet Gynaecol. 1999;106:1265–1272
  34. Critchley HO, Wallace WH. Impact of cancer treatment on uterine function. J Natl Cancer Inst Monogr. 2005;34:64–68
  35. Larsen EC, Schmiegelow K, Rechnitzer C, Loft A, Muller J, Andersen AN. Radiotherapy at a young age reduces uterine volume of childhood cancer survivors. Acta Obstet Gynecol Scand. 2004;83:96–102
  36. Partridge AH, Gelber S, Peppercorn J, Sampson E, Knudsen K, Laufer M, et al Web-based survey of fertility issues in young women with breast cancer. J Clin Oncol. 2004;22:4174–4183
  37. The American Society of Reproductive Medicine—The Ethics Committee. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83:1622–1628
  38. Kim SS. Fertility preservation in female cancer patients: current developments and future directions. Fertil Steril. 2006;85:1–11
  39. Wells SA, Gunnells JC, Leslie JB, Schneider AS, Sherwood LM, Gutman RA. Transplantation of the parathyroid glands in man. Transplant Proc. 1977;9:241–243
  40. Wells SA, Stirman JA, Bolman RM, Gunnells JC. Transplantation of the parathyroid glands. Clinical and experimental results. Surg Clin North Am. 1978;58:391–402
  41. Jeremias E, Bedaiwy MA, Gurunluoglu R, Biscotti CV, Siemionow M, Falcone T. Heterotopic autotransplantation of the ovary with microvascular anastomosis: a novel surgical technique. Fertil Steril. 2002;77:1278–1282
  42. Oktay K, Economos K, Kan M, Rucinski J, Veeck L, Rosenwaks Z. Endocrine function and oocyte retrieval after autologous transplantation of ovarian cortical strips to the forearm. JAMA. 2001;286:1490–1493
  43. Oktay K, Kan MT, Rosenwaks Z. Recent progress in oocyte and ovarian tissue cryopreservation and transplantation. Curr Opin Obstet Gynecol. 2001;13:263–268
  44. Oktay K, Buyuk E, Veeck L, Zaninovic N, Xu K, Takeuchi T, et al. Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet. 2004;363:837–840
  45. Meirow D, Levron J, Eldar-Geva T, Hardan I, Fridman E, Yemini Z, et al. Monitoring the ovaries after autotransplantation of cryopreserved ovarian tissue: endocrine studies, in vitro fertilization cycles, and live birth. Fertil Steril. 2007;87:418;e417
  46. Demeestere I, Simon P, Buxant F, Robin V, Fernandez SA, Centner J, et al. Ovarian function and spontaneous pregnancy after combined heterotopic and orthotopic cryopreserved ovarian tissue transplantation in a patient previously treated with bone marrow transplantation: case report. Hum Reprod. 2006;21:2010–2014
  47. Demeestere I, Simon P, Emiliani S, Delbaere A, Englert Y. Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease. Oncologist. 2007;12:1437–1442
  48. Silber SJ, Lenahan KM, Levine DJ, Pineda JA, Gorman KS, Friez MJ, et al. Ovarian transplantation between monozygotic twins discordant for premature ovarian failure. N Engl J Med. 2005;353:58–63
  49. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17:121–155
  50. Oktay K, Karlikaya G. Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med. 2000;342:1919
  51. Radford JA, Lieberman BA, Brison DR, Smith AR, Critchlow JD, Russell SA, et al. Orthotopic reimplantation of cryopreserved ovarian cortical strips after high-dose chemotherapy for Hodgkin's lymphoma. Lancet. 2001;357:1172–1175
  52. Schmidt KL, Andersen CY, Loft A, Byskov AG, Ernst E, Andersen AN. Follow-up of ovarian function post-chemotherapy following ovarian cryopreservation and transplantation. Hum Reprod. 2005;20:3539–3546
  53. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, et al. Restoration of ovarian function after orthotopic (intraovarian and periovarian) transplantation of cryopreserved ovarian tissue in a woman treated by bone marrow transplantation for sickle cell anaemia: case report. Hum Reprod. 2006;21:183–188
  54. Oktay K. Spontaneous conceptions and live birth after heterotopic ovarian transplantation: is there a germline stem cell connection?. Hum Reprod. 2006;21:1345–1348
  55. Baird DT, Webb R, Campbell BK, Harkness LM, Gosden RG. Long-term ovarian function in sheep after ovariectomy and transplantation of autografts stored at −196°C. Endocrinology. 1999;140:462–471
  56. Baird DT, Campbell B, de Souza C, Telfer E. Long-term ovarian function in sheep after ovariectomy and autotransplantation of cryopreserved cortical strips. Eur J Obstet Gynecol Reprod Biol. 2004;113:S55–S59
  57. Kim SS, Hwang IT, Lee HC. Heterotopic autotransplantation of cryobanked human ovarian tissue as a strategy to restore ovarian function. Fertil Steril. 2004;82:930–932
  58. Callejo J, Salvador C, Miralles A, Vilaseca S, Lailla JM, Balasch J. Long-term ovarian function evaluation after autografting by implantation with fresh and frozen–thawed human ovarian tissue. J Clin Endocrinol Metab. 2001;86:4489–4494
  59. Kim SS, Yang HW, Kang HG, Lee HH, Lee HC, Ko DS, et al. Quantitative assessment of ischemic tissue damage in ovarian cortical tissue with or without antioxidant (ascorbic acid) treatment. Fertil Steril. 2004;82:679–685
  60. Nugent D, Newton H, Gallivan L, Gosden RG. Protective effect of vitamin E on ischaemia–reperfusion injury in ovarian grafts. J Reprod Fertil. 1998;114:341–346
  61. Hilders CG, Baranski AG, Peters L, Ramkhelawan A, Trimbos JB. Successful human ovarian autotransplantation to the upper arm. Cancer. 2004;101:2771–2778
  62. Muller G, Von Theobald P, Levy G, Roffe JL, Le Porrier M. [First heterotopic ovarian autotransplantation in the female]. J Gynecol Obstet Biol Reprod (Paris). 1988;17:97–102
  63. Newton H, Aubard Y, Rutherford A, Sharma V, Gosden R. Low temperature storage and grafting of human ovarian tissue. Hum Reprod. 1996;11:1487–1491
  64. Candy CJ, Wood MJ, Whittingham DG. Effect of cryoprotectants on the survival of follicles in frozen mouse ovaries. J Reprod Fertil. 1997;110:11–19
  65. Gunasena KT, Villines PM, Critser ES, Critser JK. Live births after autologous transplant of cryopreserved mouse ovaries. Hum Reprod. 1997;12:101–106
  66. Aubard Y, Piver P, Cogni Y, Fermeaux V, Poulin N, Driancourt MA. Orthotopic and heterotopic autografts of frozen–thawed ovarian cortex in sheep. Hum Reprod. 1999;14:2149–2154
  67. Nisolle M, Casanas-Roux F, Qu J, Motta P, Donnez J. Histological and ultrastructural evaluation of fresh and frozen–thawed human ovarian xenografts in nude mice. Fertil Steril. 2000;74:122–129
  68. Liu J, Van der Elst J, Van den Broecke R, Dhont M. Early massive follicle loss and apoptosis in heterotopically grafted newborn mouse ovaries. Hum Reprod. 2002;17:605–611
  69. Jadoul P, Donnez J, Dolmans MM, Squifflet J, Lengele B, Martinez-Madrid B. Laparoscopic ovariectomy for whole human ovary cryopreservation: technical aspects. Fertil Steril. 2007;87:971–975
  70. Bedaiwy MA, Jeremias E, Gurunluoglu R, Hussein MR, Siemianow M, Biscotti C, et al. Restoration of ovarian function after autotransplantation of intact frozen–thawed sheep ovaries with microvascular anastomosis. Fertil Steril. 2003;79:594–602
  71. Imhof M, Bergmeister H, Lipovac M, Rudas M, Hofstetter G, Huber J. Orthotopic microvascular re-anastomosis of whole cryopreserved ovine ovaries resulting in pregnancy and life birth. Fertil Steril. 2006;85:1208–1215
  72. Bedaiwy MA, Hussein MR, Biscotti C, Falcone T. Cryopreservation of intact human ovary with its vascular pedicle. Hum Reprod. 2006;21:3258–3269
  73. Bedaiwy MA, Falcone T. Harvesting and autotransplantation of vascularized ovarian grafts: approaches and techniques. Reprod Biomed Online. 2007;14:360–371
  74. Bisharah M, Tulandi T. Laparoscopic preservation of ovarian function: an underused procedure. Am J Obstet Gynecol. 2003;188:367–370
  75. Wang X, Chen H, Yin H, Kim SS, Lin Tan S, Gosden RG. Fertility after intact ovary transplantation. Nature. 2002;415:385
  76. Courbiere B, Massardier J, Salle B, Mazoyer C, Guerin JF, Lornage J. Follicular viability and histological assessment after cryopreservation of whole sheep ovaries with vascular pedicle by vitrification. Fertil Steril. 2005;84(Suppl. 2):1065–1071
  77. Gosden RG, Baird DT, Wade JC, Webb R. Restoration of fertility to oophorectomized sheep by ovarian autografts stored at −196 degrees C. Hum Reprod. 1994;9:597–603
  78. Mhatre P, Mhatre J, Magotra R. Ovarian transplant: a new frontier. Transplant Proc. 2005;37:1396–1398
  79. Leporrier M, von Theobald P, Roffe JL, Muller G. A new technique to protect ovarian function before pelvic irradiation. Heterotopic ovarian autotransplantation. Cancer. 1987;60:2201–2204
  80. Pickering SJ, Braude PR, Johnson MH, Cant A, Currie J. Transient cooling to room temperature can cause irreversible disruption of the meiotic spindle in the human oocyte. Fertil Steril. 1990;54:102–108
  81. Coticchio G, Bonu MA, Bianchi V, Flamigni C, Borini A. Criteria to assess human oocyte quality after cryopreservation. Reprod Biomed Online. 2005;11:421–427
  82. Newton H, Fisher J, Arnold JR, Pegg DE, Faddy MJ, Gosden RG. Permeation of human ovarian tissue with cryoprotective agents in preparation for cryopreservation. Hum Reprod. 1998;13:376–380
  83. Fuller B, Paynter S. Fundamentals of cryobiology in reproductive medicine. Reprod Biomed Online. 2004;9:680–691
  84. Bedaiwy MA, Jeremias E, Gurunluoglu R, Hussein MR, Siemianow M, Biscotti C, et al. Restoration of ovarian function after autotransplantation of intact frozen–thawed sheep ovaries with microvascular anastomosis. Fertil Steril. 2003;79:594–602
  85. Arav A, Revel A, Nathan Y, Bor A, Gacitua H, Yavin S, et al Oocyte recovery, embryo development and ovarian function after cryopreservation and transplantation of whole sheep ovary. Hum Reprod. 2005;20:3554–3559
  86. Imhof M, Bergmeister H, Lipovac M, Rudas M, Hofstetter G, Huber J. Orthotopic microvascular reanastomosis of whole cryopreserved ovine ovaries resulting in pregnancy and live birth. Fertil Steril. 2006;85(Suppl 1):1208–5
  87. Revel A, Elami A, Bor A, Yavin S, Natan Y, Arav A. Whole sheep ovary cryopreservation and transplantation. Fertil Steril. 2004;82:1714–1715
  88. Hovatta O. Methods for cryopreservation of human ovarian tissue. Reprod Biomed Online. 2005;10:729–734
  89. Martinez-Madrid B, Dolmans MM, Van Langendonckt A, Defrere S, Donnez J. Freeze–thawing intact human ovary with its vascular pedicle with a passive cooling device. Fertil Steril. 2004;82:1390–1394
  90. Martinez-Madrid B, Donnez J. Technical challenges in freeze–thawing of human ovary: reply of the authors. Fertil Steril. 2005;83:1069–1070
  91. Martinez-Madrid B, Camboni A, Dolmans MM, Nottola S, Van Langendonckt A, Donnez J. Apoptosis and ultrastructural assessment after cryopreservation of whole human ovaries with their vascular pedicle. Fertil Steril. 2007;87:1153–1165
  92. Camboni A, Martinez-Madrid B, Dolmans MM, Macchiarelli G, Donnez J, Nottola SA. Contribution of transmission electron microscopy to the study of human ovarian tissue integrity after enzymatic isolation, cryopreservation or xenografting. Fertil Steril. 2005;84:S104
  93. Schmidt KL, Ernst E, Byskov AG, Nyboe Andersen A, Yding Andersen C. Survival of primordial follicles following prolonged transportation of ovarian tissue prior to cryopreservation. Hum Reprod. 2003;18:2654–2659
  94. Weissman A, Gotlieb L, Colgan T, Jurisicova A, Greenblatt EM, Casper RF. Preliminary experience with subcutaneous human ovarian cortex transplantation in the NOD–SCID mouse. Biol Reprod. 1999;60:1462–1467
  95. Yin H, Wang X, Kim SS, Chen H, Tan SL, Gosden RG. Transplantation of intact rat gonads using vascular anastomosis: effects of cryopreservation, ischaemia and genotype. Hum Reprod. 2003;18:1165–1172
  96. Al-aghbari AM, Menino AR. Survival of oocytes recovered from vitrified sheep ovarian tissues. Anim Reprod Sci. 2002;71:101–110
  97. Goding JR, McCracken JA, Baird DT. The study of ovarian function in the ewe by means of a vascular autotransplantation technique. J Endocrinol. 1967;39:37–52
  98. Scott JR, Keye WR, Poulson AM, Reynolds WA. Microsurgical ovarian transplantation in the primate. Fertil Steril. 1981;36:512–515
  99. Cakir B, Akan M, Akoz T. [The management of size discrepancies in microvascular anastomoses]. Acta Orthop Traumatol Turc. 2003;37:379–385
  100. Lopez-Monjardin H, de la Pena-Salcedo JA. Techniques for management of size discrepancies in microvascular anastomosis. Microsurgery. 2000;20:162–166
  101. de la Pena-Salcedo JA, Cuesy C, Lopez-Monjardin H. Experimental microvascular sleeve anastomosis in size discrepancy vessels. Microsurgery. 2000;20:173–175
  102. Boom H, Mallat MJ, de Fijter JW, Zwinderman AH, Paul LC. Delayed graft function influences renal function, but not survival. Kidney Int. 2000;58:859–866
  103. Nakagawa K, Koo DD, Davies DR, Gray DW, McLaren AJ, Welsh KI, et al. Lecithinized superoxide dismutase reduces cold ischemia-induced chronic allograft dysfunction. Kidney Int. 2002;61:1160–1169
  104. Shoskes DA, Halloran PF. Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol. 1996;155:1831–1840
  105. Oktay K, Nugent D, Newton H, Salha O, Chatterjee P, Gosden RG. Isolation and characterization of primordial follicles from fresh and cryopreserved human ovarian tissue. Fertil Steril. 1997;67:481–486
  106. Donnez J, Dolmans MM, Pirard C, Langendonckt AV, Demylle D, Jadoul P, et al. Allograft of ovarian cortex between two genetically non-identical sisters: Case Report. Hum Reprod. 2007;
  107. Grimbizis GF, Camus M, Tarlatzis BC, Bontis JN, Devroey P. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update. 2001;7:161–174
  108. Pearson H. Infertility researchers target uterus transplant. Nature. 2007;445:466–467
  109. Eraslan S, Hamernik RJ, Hardy JD. Replantation of uterus and ovaries in dogs, with successful pregnancy. Arch Surg. 1966;92:9–12
  110. Racho El-Akouri R, Wranning CA, Molne J, Kurlberg G, Brannstrom M. Pregnancy in transplanted mouse uterus after long-term cold ischaemic preservation. Hum Reprod. 2003;18:2024–2030
  111. Turunen A. [On traumatic amenorrhea. 2 cases of endometrium transplantation which led to the birth of a full-term infant]. Gynaecologia. 1967;164:12–23
  112. Fageeh W, Raffa H, Jabbad H, Marzouki A. Transplantation of the human uterus. Int J Gynaecol Obstet. 2002;76:245–251
  113. Hill GR, Ferrara JL. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood. 2000;95:2754–2759
  114. Murai M, Yoneyama H, Ezaki T, Suematsu M, Terashima Y, Harada A, et al. Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction. Nat Immunol. 2003;4:154–160
  115. Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, et al. Relation of an IL-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med. 2003;349:2201–2210
  116. Rocha V, Franco RF, Porcher R, Bittencourt H, Silva WA, Latouche A, et al. Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. Blood. 2002;100:3908–3918
  117. Holler E, Rogler G, Herfarth H, Brenmoehl J, Wild PJ, Hahn J, et al Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood. 2004;104:889–894
  118. van Rood JJ. Immunologic HLA-typing. A tool for selection of recipients in transplantation and for detection of disposition to certain diseases (author's transl). Klin Wochenschr. 1977;55:1209–1215
  119. Bertinetto FE, Dall'Omo AM, Mazzola GA, Rendine S, Berrino M, Bertola L, et al. Role of non-HLA genetic polymorphisms in graft-versus-host disease after haematopoietic stem cell transplantation. Int J Immunogenet. 2006;33:375–384
  120. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med. 1991;324:667–674
  121. Almawi WY, Lipman ML, Stevens AC, Zanker B, Hadro ET, Strom TB. Abrogation of glucocorticoid-mediated inhibition of T cell proliferation by the synergistic action of IL-1, IL-6 and IFN gamma. J Immunol. 1991;146:3523–3527
  122. Nydegger UE, Riedler GF, Flegel WA. Histoblood groups other than HLA in organ transplantation. Transplant Proc. 2007;39:64–68
  123. Alonso A, Fernandez C, Villaverde P, Garcia R, Aguirrezabalaga J, Gomez M, et al. Kidney-pancreas transplants: is it so difficult to start a program?. Transplant Proc. 2005;37:1455–1456
  124. Ringe B, Moritz M, Zeldin G, Soriano H. What is the best immunosuppression in living donor liver transplantation?. Transplant Proc. 2005;37:2169–2171
  125. Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol Today. 1993;14:353–356
  126. Doria A, Iaccarino L, Arienti S, Ghirardello A, Zampieri S, Rampudda ME, et al. Th2 immune deviation induced by pregnancy: the two faces of autoimmune rheumatic diseases. Reprod Toxicol. 2006;22:234–241
  127. Ostensen M, Forger F, Villiger PM. Cytokines and pregnancy in rheumatic disease. Ann N Y Acad Sci. 2006;1069:353–363
  128. Munoz-Valle JF, Vazquez-Del Mercado M, Garcia-Iglesias T, Orozco-Barocio G, Bernard-Medina G, Martinez-Bonilla G, et al. T(H)1/T(H)2 cytokine profile, metalloprotease-9 activity and hormonal status in pregnant rheumatoid arthritis and systemic lupus erythematosus patients. Clin Exp Immunol. 2003;131:377–384
  129. Meregalli E, Biggioggero M, Borghi O, Meroni P, Cimaz R. In vivo effects of maternal immunosuppression during pregnancy on the immune function of newborn infants. Arh Hig Rada Toksikol. 2005;56:151–156
  130. Nielsen GL, Sorensen HT, Larsen H, Pedersen L. Risk of adverse birth outcome and miscarriage in pregnant users of non-steroidal anti-inflammatory drugs: population based observational study and case–control study. Br Med J. 2001;322:266–270
  131. Chan LY, Yuen PM. Risk of miscarriage in pregnant users of NSAIDs. More information is needed to be able to interpret study's results. Br Med J. 2001;322:1365–1366
  132. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. BMJ. 2003;327:368
  133. Kozer E, Costei AM, Boskovic R, Nulman I, Nikfar S, Koren G. Effects of aspirin consumption during pregnancy on pregnancy outcomes: meta-analysis. Birth Defects Res B Dev Reprod Toxicol. 2003;68:70–84
  134. Urban R, Lemancewicz A, Przepiesc J, Urban J, Kretowska M. Antenatal corticosteroid therapy: a comparative study of dexamethasone and betamethasone effects on fetal Doppler flow velocity waveforms. Eur J Obstet Gynecol Reprod Biol. 2005;120:170–174
  135. Schatz M, Patterson R, Zeitz S, O'Rourke J, Melam H. Corticosteroid therapy for the pregnant asthmatic patient. JAMA. 1975;233:804–807
  136. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, et al. Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology. 2000;62:385–392
  137. Bermas BL. Use of immunosuppressive drugs in pregnancy,. http://www.uptodateonline.com/utd/content/author.do?authorId=215316 2006.
  138. Cowchock FS, Reece EA, Balaban D, Branch DW, Plouffe L. Repeated fetal losses associated with antiphospholipid antibodies; a collaborative randomized trial comparing prednisone with low-dose heparin treatment. Am J Obstet Gynecol. 1992;166:1318–1323
  139. Guller S, Kong L, Wozniak R, Lockwood CJ. Reduction of extracellular matrix protein expression in human amnion epithelial cells by glucocorticoids: a potential role in preterm rupture of the fetal membranes. J Clin Endocrinol Metab. 1995;80:2244–2250
  140. Reinisch JM, Simon NG, Karow WG, Gandelman R. Prenatal exposure to prednisone in humans and animals retards intrauterine growth. Science. 1978;202:436–438
  141. Scott JR. Fetal growth retardation associated with maternal administration of immunosuppressive drugs. Am J Obstet Gynecol. 1977;128:668–676
  142. Cederqvist LL, Merkatz IR, Litwin SD. Fetal immunoglobin synthesis following maternal immunosuppression. Am J Obstet Gynecol. 1977;129:687–690
  143. Czeizel AE, Toth M. Birth weight, gestational age and medications during pregnancy. Int J Gynaecol Obstet. 1998;60:245–249
  144. Kraus AM. Developmental cataracts. N Y State J Med. 1975;75:1757–1758
  145. Cote CJ, Meuwissen HJ, Pickering RJ. Effects on the neonate of prednisone and azathioprine administered to the mother during pregnancy. J Pediatrics. 1974;85:324–328
  146. Price HV, Salaman JR, Laurence KM, Langmaid H. Immunosuppressive drugs and the foetus. Transplantation. 1976;21:294–298
  147. Benediktsson R, Lindsay RS, Noble J, Seckl JR, Edwards CR. Glucocorticoid exposure in utero: new model for adult hypertension. Lancet. 1993;341:339–341
  148. Jobe AH, Wada N, Berry LM, Ikegami M, Ervin MG. Single and repetitive maternal glucocorticoid exposures reduce fetal growth in sheep. Am J Obstet Gynecol. 1998;178:880–885
  149. French NP, Hagan R, Evans SF, Godfrey M, Newnham JP. Repeated antenatal corticosteroids: size at birth and subsequent development. Am J Obstet Gynecol. 1999;180:114–121
  150. Abbasi S, Hirsch D, Davis J, Tolosa J, Stouffer N, Debbs R, et al. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome. Am J Obstet Gynecol. 2000;182:1243–1249
  151. Spinillo A, Viazzo F, Colleoni R, Chiara A, Cerbo RA, Fazzi E. Two-year infant neurodevelopmental outcome after single or multiple antenatal courses of corticosteroids to prevent complications of prematurity. Am J Obstet Gynecol. 2004;191:217–224
  152. Buckley LM, Bullaboy CA, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum. 1997;40:971–973
  153. Milunsky A, Graef JW, Gaynor MF. Methotrexate-induced congenital malformations. J Pediatr. 1968;72:790–795
  154. Report from the Registration Committee of the European Dialysis and Transplant Association. Successful pregnancies in women treated by dialysis and kidney transplantation. Br J Obstet Gynaecol. 1980;87:839–845
  155. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML. Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology. 1990;99:443–446
  156. Moskovitz DN, Bodian C, Chapman ML, Marion JF, Rubin PH, Scherl E, et al. The effect on the fetus of medications used to treat pregnant inflammatory bowel-disease patients. Am J Gastroenterol. 2004;99:656–661
  157. Davison JM, Dellagrammatikas H, Parkin JM. Maternal azathioprine therapy and depressed haemopoiesis in the babies of renal allograft patients. Br J Obstet Gynaecol. 1985;92:233–239
  158. Pabelick C, Kemmer F, Koletzko B. [Clinical findings in newborn infants of mothers with kidney transplants]. Monatsschr Kinderheilkd. 1991;139:136–140
  159. Ostensen M. Disease specific problems related to drug therapy in pregnancy. Lupus. 2004;13:746–750
  160. Shaheen FA, al-Sulaiman MH, al-Khader AA. Long-term nephrotoxicity after exposure to cyclosporine in utero. Transplantation. 1993;56:224–225
  161. Jain AB, Reyes J, Marcos A, Mazariegos G, Eghtesad B, Fontes PA, et al Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation. 2003;76:827–832
  162. Mason RJ, Thomson AW, Whiting PH, Gray ES, Brown PA, Catto GR, et al. Cyclosporine-induced fetotoxicity in the rat. Transplantation. 1985;39:9–12
  163. Bar Oz B, Hackman R, Einarson T, Koren G. Pregnancy outcome after CsA therapy during pregnancy: a meta-analysis. Transplantation. 2001;71:1051–1055
  164. Cockburn I, Krupp P, Monka C. Present experience of Sandimmun in pregnancy. Transplant Proc. 1989;21:3730–3732
  165. Hussein MM, Mooij JM, Roujouleh H. Cyclosporine in the treatmen of lupus nephritis including 2 patients treated during pregnancy. Clin Nephrol. 1993;40:160–163
  166. Armenti VT, Ahlswede KM, Ahlswede BA, Jarrell BE, Moritz MJ, Burke JF. National transplantation pregnancy registry: outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients. Transplantation. 1994;57:502–506
  167. Lamarque V, Leleu MF, Monka C, Krupp P. Analysis of 629 pregnancy outcomes in transplant recipients treated with Sandimmun. Transplant Proc. 1997;29:2480
  168. Barrou BM, Gruessner AC, Sutherland DE, Gruessner RW. Pregnancy after pancreas transplantation in the cyclosporin era: report from the International Pancreas Transplant Registry. Transplantation. 1998;65:524–527
  169. Pilarski LM, Yacyshyn BR, Lazarovits AI. Analysis of peripheral blood lymphocyte populations and immune function from children exposed to cyclosporine or to azathioprine in utero. Transplantation. 1994;57:133–144
  170. Di Paolo S, Schena A, Morrone LF, Manfredi G, Stallone G, Derosa C, et al. Immunologic evaluation during the first year of life of infants born to cyclosporine treated female kidney transplant recipients. Transplantation. 2000;69:2049–2054
  171. Cimaz R, Meregalli E, Biggioggero M, Borghi O, Tincani A, Motta M, et al. Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy. Toxicol Lett. 2004;149:155–162
  172. Moretti ME, Sgro M, Johnson DW, Sauve RS, Woolgar MJ, Taddio A, et al. Cyclosporine excretion into breast milk. Transplantation. 2003;75:2144–2146
  173. Stanley CW, Gottlieb R, Zager R, Eisenberg J, Richmond R, Moritz MJ, et al. Developmental well-being in offspring of women receiving cyclosporine post-renal transplant. Transplant Proc. 1999;31:241–242
  174. Sgro MD, Barozzino T, Mirghani HM, Sermer M, Moscato L, Akoury H, et al. Pregnancy outcome post renal transplantation. Teratology. 2002;65:5–9
  175. Skomsvoll JF, Wallenius M, Koksvik HS, Rodevand E, Salvesen KA, Spigset O, et al. Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation. Nat Clin Pract Rheumatol. 2007;3:156–164
  176. Tabilio A, Falzetti F, Zei T, De Ioanni M, Bonifacio E, Battelli F, et al. Graft engineering for allogeneic haploidentical stem cell transplantation. Blood Cells Mol Dis. 2004;33:274–280
  177. Brinster RL, Zimmermann JW. Spermatogenesis following male germ-cell transplantation. Proc Natl Acad Sci USA. 1994;91:11298–11302
  178. Brinster RL, Avarbock MR. Germline transmission of donor haplotype following spermatogonial transplantation. Proc Natl Acad Sci USA. 1994;91:11303–11307
  179. Clouthier DE, Avarbock MR, Maika SD, Hammer RE, Brinster RL. Rat spermatogenesis in mouse testis. Nature. 1996;381:418–421
  180. Ogawa T, Arechaga JM, Avarbock MR, Brinster RL. Transplantation of testis germinal cells into mouse seminiferous tubules. Int J Dev Biol. 1997;41:111–122
  181. Avarbock MR, Brinster CJ, Brinster RL. Reconstitution of spermatogenesis from frozen spermatogonial stem cells. Nat Med. 1996;2:693–696
  182. Schlatt S, Nieschlag E. [Germ cell transplantation as a tool for fertility preservation of oncological patients]. Klin Padiatr. 2001;213:250–254
  183. Fujita K, Ohta H, Tsujimura A, Takao T, Miyagawa Y, Takada S, et al. Transplantation of spermatogonial stem cells isolated from leukemic mice restores fertility without inducing leukemia. J Clin Invest. 2005;115:1855–1861
  184. Mikkola M, Sironen A, Kopp C, Taponen J, Sukura A, Vilkki J, et al. Transplantation of normal boar testicular cells resulted in complete focal spermatogenesis in a boar affected by the immotile short-tail sperm defect. Reprod Domest Anim. 2006;41:124–128
  185. Bukovsky A, Copas P, Virant-Klun I. Potential new strategies for the treatment of ovarian infertility and degenerative diseases with autologous ovarian stem cells. Expert Opin Biol Ther. 2006;6:341–365
  186. Perez GI, Jurisicova A, Wise L, Lipina T, Kanisek M, Bechard A, et al. Absence of the proapoptotic Bax protein extends fertility and alleviates age-related health complications in female mice. Proc Natl Acad Sci USA. 2007;104:5229–5234
  187. Poirot C, Vacher-Lavenu MC, Helardot P, Guibert J, Brugieres L, Jouannet P. Human ovarian tissue cryopreservation: indications and feasibility. Hum Reprod. 2002;17:1447–1452
  188. Rosoff PM, Katsur ML. Preserving fertility in young cancer patients: a medical, ethical and legal challenge. J Philos Sci Law. 2003;3:Available online at www.psljournal.com/archives/papers/preservingFert.cfm
  189. Dudzinski DM. Ethical issues in fertility preservation for adolescent cancer survivors: oocyte and ovarian tissue cryopreservation. J Pediatr Adolesc Gynecol. 2004;17:97–102
  190. Bobbert M. Ethical questions concerning research on human embryos, embryonic stem cells and chimeras. Biotechnol J. 2006;1:1352–1369
  191. Clowse ME, Magder L, Petri M. Cyclophosphamide for lupus during pregnancy. Lupus. 2005;14:593–597
  192. Ostensen M, Khamashta M, Lockshin M, Parke A, Brucato A, Carp H, et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther. 2006;8:209
  193. Burdett DN, Waterfield JD, Shah RM. Vertical development of the secondary palate in hamster embryos following exposure to 6-mercaptopurine. Teratology. 1988;37:591–597
  194. Kavlock RJ, Rehnberg BF, Rogers EH. Chlorambucil induced congenital renal hypoplasia: effects on basal renal function in the developing rat. Toxicology. 1986;40:247–258
  195. Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Management of the pregnant patient with Hodgkin's disease. Ann Intern Med. 1981;95:669–675
  196. Skalko RG, Gold MP. Teratogenicity of methotrexate in mice. Teratology. 1974;9:159–163
  197. Buckley LM, Bullaboy CA, Leichtman L, Marquez M. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum. 1997;40:971–973

 M.A.B. has nothing to disclose. A.Y.S. has nothing to disclose. T.F. has nothing to disclose.

PII: S0015-0282(08)03306-2

doi: 10.1016/j.fertnstert.2008.08.009

Fertility and Sterility
Volume 90, Issue 6 , Pages 2031-2055 , December 2008

Article Tools

* Image Usage & Resolution